Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalia Stoeva"'
Autor:
Imrich Jonner, V. Lostakova, Małgorzata Sobiecka, F. Petrik, Peter Paluch, Martina Plačková, A. Jakic, J. Lnenicka, Štefan Tóth, Hana Suldova, T. Tran, Ladislav Dušek, Martina Sterclova, A. Szymanowska-Narioch, Aleksander Kania, M.J. Studnicka, Jan Anton, T. Stachura, Renata Králová, Pavlina Musilova, Richard Tyl, Mordechai R. Kramer, Marta Hájková, Ladislav Lacina, Martina Doubková, T. Pejcic, Marina Roksandic Milenkovic, L. Borucki, J. Plutinsky, V. Vucinic-Mihailovic, Margita Bučeková, Robert Slivka, Imre Lajkó, Pawel Sliwinski, Sebastian Majewski, A. Nowicka, Bohumil Matula, S. Mladinov, Zoltán Balikó, Ilona Binková, Anikó Bohács, Veronika Müller, P. Jurek, Natalia Stoeva, V. Rihak, Lenka Šišková, Radka Bittenglova, Pavlína Lisá, T. Snizek, Vladimir Bartos, R. Mokosova, Mária Szilasi, S. Suissa, T. R. Petkovic, Zsuzsanna Szalai, D. Jovanovic, Štefan Laššán, D. Dolezal, H. Hortvikova, Nesrin Mogulkoc, Miklós Zsiray, M. Zurkova, Beata Zolnowska, Martina Vasakova, Jana Psikalova, P. Reiterer, Katarzyna Lewandowska, Marzena Trzaska-Sobczak, Jasna Tekavec-Trkanjec, M. Martusewia-Boros, Karel Hejduk, R. Hrdina, Jiří Homolka, R. Vysehradsky
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-9 (2020)
Respiratory Research
Respiratory Research
Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of follow-up are limited. Here, we describe the large European MultiPartner IPF Regist
Autor:
Ondřej Májek, Jakub Gregor, Nesrin Mogulkoć, Katarzyna Lewandowska, Martina Šterclová, Veronika Müller, Marta Hájková, Mordechai R. Kramer, Jasna Tekavec-Trkanjec, Dragana Jovanović, Michael Studnicka, Natalia Stoeva, Klaus-Uwe Kirchgässler, Simona Littnerová, Ladislav Dušek, Martina Koziar Vašáková
Publikováno v:
PLOS ONE. 17:e0273854
Background There is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis (IPF) is diagnosed with a lower degree of diagnostic certainty. We report on outcomes of treatm
Publikováno v:
Phlebology. 34(7):453-458
Objectives The aim of the study is to find how concomitant deep venous thrombosis (DVT) changes the clinical course of pulmonary embolism. Methods Three hundred and five patients with pulmonary embolism were examined and grouped into DVT and non-DVT
Publikováno v:
Respiratory Medicine. 135:57-61
The assessment of the clinical symptoms is the weakest link of the pulmonary embolism (PE) diagnostic algorithm. Despite the presence of highly sensitive and specific imaging methods, verifying PE remains difficult due to nonspecific clinical symptom
Autor:
Natalia Stoeva, Vessela S. Koleva
Publikováno v:
Folia Medica, Vol 58, Iss 1, Pp 64-66 (2016)
Prothrombin 20210 G>A mutation is the second most frequent inherited factor increasing the risk for developing venous thromboembolism (VTE). The risk for VTE in homozygous carriers of this mutation is not well studied because of their rarity are rare